Today’s Hot List: Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ), Waste Management, Inc. (NYSE:WM), Twitter Inc (NYSE:TWTR), OFG Bancorp (NYSE:OFG),

Aralez Pharmaceuticals Inc (NASDAQ:ARLZ)‘s stock had its “outperform” rating reiterated by Zacks Investment Research in a research report issued on Friday, Market Beat Ratings reports.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) belongs to Healthcare sector. Its weekly performance is -1.34%. On last trading day company shares ended up at $5.91. Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) distance from 50-day simple moving average (SMA50) is 6.29%.

Waste Management, Inc. (NYSE:WM) declared a quarterly dividend. Shareholders of record on Monday, March 7th will be given a dividend of 0.41 per share on Friday, March 18th. This represents a $1.64 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Thursday, March 3rd. This is an increase from Waste Management’s previous quarterly dividend of $0.39.

Waste Management, Inc. (NYSE:WM) shares moved down -0.21% in last trading session and ended the day at $57.15. WM Gross Margin is 44.40% and its return on assets is 3.70%. Waste Management, Inc. (NYSE:WM) quarterly performance is 7.58%.

On 28 February, Twitter Inc (NYSE:TWTR) launched #Position of strength campaign to empower women to raise voices against any form of discrimination.

Twitter Inc (NYSE:TWTR) shares moved up 0.26% in last trading session and ended the day at $19.36. TWTR Gross Margin is 67.10% and its return on assets is -8.50%. Twitter Inc (NYSE:TWTR) quarterly performance is -23.78%.

OFG Bancorp (NYSE:OFG) announced a quarterly dividend. Investors of record on Tuesday, March 29th will be given a dividend of 0.06 per share on Friday, April 15th. This represents a $0.24 annualized dividend and a dividend yield of 4.55%. The ex-dividend date of this dividend is Thursday, March 24th.

OFG Bancorp (NYSE:OFG) ended the last trading day at $6.84. Company weekly volatility is calculated as 5.72% and price to cash ratio as 0.53. OFG Bancorp (NYSE:OFG) showed a weekly performance of 17.32%.

Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) announced that, positive interim data from the Company’s phase I/II dose-ranging clinical trial of PRX-102 for the treatment of Fabry disease presented on March 3, 2016 at 3:15 PM PT at the Lysosomal Disease Network 12th Annual WORLDSymposium 2016 in San Diego, CA. PRX-102 is a recombinant plant cell expressed, Pegylated modified version of the human alpha-Galactosidase-A enzyme.

Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) shares moved down -0.99% in last trading session and ended the day at $0.88. Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) quarterly performance is -13.71%.

Leave a Reply

Your email address will not be published. Required fields are marked *